Приказ основних података о документу
Markers of coagulation activation and enhanced fibrinolysis in Gaucher type 1 patient: Effects of enzyme replacement therapy
dc.creator | Mitrović, Mirjana | |
dc.creator | Šumarac, Zorica | |
dc.creator | Antić, Darko | |
dc.creator | Bogdanović, Andrija | |
dc.creator | Elezović, Ivo | |
dc.creator | Vukosavljević, Dragana | |
dc.creator | Ignjatović, Svetlana | |
dc.creator | Majkić-Singh, Nada | |
dc.creator | Suvajdzić, Nada | |
dc.date.accessioned | 2019-09-02T11:30:14Z | |
dc.date.available | 2019-09-02T11:30:14Z | |
dc.date.issued | 2012 | |
dc.identifier.issn | 1079-9796 | |
dc.identifier.uri | https://farfar.pharmacy.bg.ac.rs/handle/123456789/1754 | |
dc.publisher | Academic Press Inc Elsevier Science, San Diego | |
dc.rights | restrictedAccess | |
dc.source | Blood Cells Molecules and Diseases | |
dc.title | Markers of coagulation activation and enhanced fibrinolysis in Gaucher type 1 patient: Effects of enzyme replacement therapy | en |
dc.type | contributionToPeriodical | |
dc.rights.license | ARR | |
dcterms.abstract | Богдановић, Aндрија; Aнтић, Дарко; Сувајдзић, Нада; Мајкић-Сингх, Нада; Вукосављевић, Драгана; Шумарац, Зорица; Митровић, Мирјана; Игњатовић, Светлана; Елезовић, Иво; | |
dc.citation.volume | 49 | |
dc.citation.issue | 1 | |
dc.citation.spage | 58 | |
dc.citation.epage | 59 | |
dc.citation.other | 49(1): 58-59 | |
dc.citation.rank | M22 | |
dc.identifier.wos | 000304730300009 | |
dc.identifier.doi | 10.1016/j.bcmd.2012.03.003 | |
dc.identifier.pmid | 22459893 | |
dc.identifier.scopus | 2-s2.0-84861329952 | |
dc.type.version | publishedVersion |